Gene · 3021
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer. | Nat Commun | 2021 | 34290255 | PubTator, text mining | PubMed |
| Development of potent dimeric inhibitors of GAS41 YEATS domain. | Cell Chem Biol | 2021 | 34289376 | PubTator, text mining | PubMed |
| The effects of aging on molecular modulators of human embryo implantation. | iScience | 2021 | 34278260 | PubTator, text mining | PubMed |
| Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas. | Sci Rep | 2021 | 34257334 | PubTator, text mining | PubMed |
| Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment. | Front Pharmacol | 2021 | 34248623 | PubTator, text mining | PubMed |
| The conserved Tpk1 regulates non-homologous end joining double-strand break repair by phosphorylation of Nej1, a homolog of the human XLF. | Nucleic Acids Res | 2021 | 34244791 | PubTator, text mining | PubMed |
| Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on "Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity" by Garbarino et al. | Transl Oncol | 2021 | 34242965 | PubTator, text mining | PubMed |
| The histone H3.3 chaperone HIRA restrains erythroid-biased differentiation of adult hematopoietic stem cells. | Stem Cell Reports | 2021 | 34242617 | PubTator, text mining | PubMed |
| The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes. | Clin Epigenetics | 2021 | 34238359 | PubTator, text mining | PubMed |
| The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database. | PLoS One | 2021 | 34234357 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19. | Front Immunol | 2021 | 34220859 | PubTator, text mining | PubMed |
| ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder. | Clin Genet | 2021 | 34216016 | PubTator, text mining | PubMed |
| Antagonising Chromatin Remodelling Activities in the Regulation of Mammalian Ribosomal Transcription. | Genes (Basel) | 2021 | 34202617 | PubTator, text mining | PubMed |
| MYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment. | Int J Mol Sci | 2021 | 34201047 | PubTator, text mining | PubMed |
| Assembly principles and stoichiometry of a complete human kinetochore module. | Sci Adv | 2021 | 34193424 | PubTator, text mining | PubMed |
| Mitotic HOOK3 phosphorylation by ERK1c drives microtubule-dependent Golgi destabilization and fragmentation. | iScience | 2021 | 34189435 | PubTator, text mining | PubMed |
| Advancing clinical genomics and precision medicine with GVViZ: FAIR bioinformatics platform for variable gene-disease annotation, visualization, and expression analysis. | Hum Genomics | 2021 | 34174938 | PubTator, text mining | PubMed |
| Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia. | BMC Med Genomics | 2021 | 34174884 | PubTator, text mining | PubMed |
| Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. | J Immunother Cancer | 2021 | 34168003 | PubTator, text mining | PubMed |
| IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer. | Oncol Lett | 2021 | 34149901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/papers?page=25